Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam P. Dicker, MD, PhD
Jefferson Medical College of Thomas Jefferson University
Study Chair - Christina Tsien
Washington University School of Medicine
Principal Investigator - Jeffrey Raizer, MD
Northwestern University
Study Chair - Martha M. Matuszak, PhD
University of Michigan
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Arizona Oncology Services Foundation
Phoenix, Arizona, United States
- Arizona Oncology-Deer Valley Center
Phoenix, Arizona, United States
- John Muir Medical Center
Walnut Creek, California, United States
- Yale University
New Haven, Connecticut, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Radiation Oncology Associates Pc
Fort Wayne, Indiana, United States
- Iu Health Methodist Hospital
Indianapolis, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Norton Health Care Pavilion - Downtown
Louisville, Kentucky, United States
- Maine Medical Center- Scarborough Campus
Scarborough, Maine, United States
- Lowell General Hospital
Lowell, Massachusetts, United States
- University of Michigan University Hospital
Ann Arbor, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- University of Rochester
Rochester, New York, United States
- Cone Health Cancer Center
Greensboro, North Carolina, United States
- Summa Akron City Hospital
Akron, Ohio, United States
- Summa Barberton Hospital
Barberton, Ohio, United States
- Lancaster General Hospital
Lancaster, Pennsylvania, United States
- Radiation Therapy Oncology Group
Philadelphia, Pennsylvania, United States
- Allegheny Cancer Center at Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
Yakima, Washington, United States
- Saint Mary'S Hospital
Green Bay, Wisconsin, United States
- Saint Vincent Hospital
Green Bay, Wisconsin, United States
- Bay Area Medical Center
Marinette, Wisconsin, United States
- Door County Cancer Center
Sturgeon Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2012
- Primary completion
- 3 Sept 2018
- Completion
- 22 Dec 2022
- Last update posted
- 29 Dec 2022
- Registered enrollment
- 182
- Registry id
- NCT01730950
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.